Figure 2. SUMF1 overexpression can be used as a diagnostic and prognostic tool in the treatment of glioma. (A) The AUC of SUMF1 from the TCGA database; (B) The AUC of SUMF1 from the XNEA database; (C–E) SUMF1 overexpression is predictive of poor prognosis.